Uriel Barkai
Technik-/Wissenschafts-/F&E-Leiter bei Beta-O2 Technologies Ltd.
Profil
Uriel Barkai is currently a Member at the International Society for Cellular Therapy, Chief Scientific Officer at Beta-O2 Technologies Ltd., a Member at The Endocrine Society, Chief Scientific Officer at GluSense Ltd., and a Member at the Society for The Study of Reproduction.
Previously, he held positions as Chief Scientific Officer & VP-Regulatory Affairs at Pluristem Ltd., Vice President-Research & Development at Polyheal Ltd., and Head-Biology Department at Carmel Biosensors Ltd.
He also worked as a Consultant at Biological Industries Israel Beit-Haemek Ltd.
Dr. Barkai received his undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
Aktive Positionen von Uriel Barkai
Unternehmen | Position | Beginn |
---|---|---|
Beta-O2 Technologies Ltd.
Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Technik-/Wissenschafts-/F&E-Leiter | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Corporate Officer/Principal | - |
The Endocrine Society | Corporate Officer/Principal | - |
Society for The Study of Reproduction | Corporate Officer/Principal | - |
GluSense Ltd.
GluSense Ltd. Electronic Equipment/InstrumentsElectronic Technology GluSense Ltd. develops technology for Continuous Glucose Monitoring. The firm develops a miniature, Long-Term, Implantable Continuous Glucose Monitoring (CGM) system for diabetes patients, this system includes a miniature sensor implanted under the skin and an external wearable unit, e.g. a watch. Its wearable unit reads the signal from the implant and provides basic display and alarms. The company was founded by Yossi Gross in 2007 and is headquartered in Rehovot, Israel. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Uriel Barkai
Unternehmen | Position | Ende |
---|---|---|
Biological Industries Israel Beit-Haemek Ltd.
Biological Industries Israel Beit-Haemek Ltd. Miscellaneous Commercial ServicesCommercial Services Biological Industries Israel Beit-Haemek Ltd. engages in the development and manufacture of cell culture media. Its products include Bio-Pure, BIOTARGET, EZ-PCR, EndoGo, and MSCgo. The company was founded in 1981 and is headquartered in Beit HaEmek, Israel. | Corporate Officer/Principal | - |
Carmel Biosensors Ltd. | Corporate Officer/Principal | - |
Medicine On Line Israel (Moli) Ltd.
Medicine On Line Israel (Moli) Ltd. Miscellaneous Commercial ServicesCommercial Services Medicine On Line Israel (Moli) Ltd. is engaged in the field of diabetes . It focuses on: Improving the quality of life and medical treatment for people with diabetes, Performing educational activities, Producing scientific publications, and training people with diabetes. The association was founded by Ludwig Nelken, Herman Wolfson, Dr Liven, and Prof. A. M. Cohen in 1954 and is headquartered in Rishon Le-Zion, Israel. | Corporate Officer/Principal | - |
Pluristem Ltd.
Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Technik-/Wissenschafts-/F&E-Leiter | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Uriel Barkai
Tel-Aviv University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 10 |
---|---|
Pluristem Ltd.
Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Commercial Services |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Commercial Services |
Polyheal Ltd.
Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel. | Health Technology |
Beta-O2 Technologies Ltd.
Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Health Technology |
The Endocrine Society | |
GluSense Ltd.
GluSense Ltd. Electronic Equipment/InstrumentsElectronic Technology GluSense Ltd. develops technology for Continuous Glucose Monitoring. The firm develops a miniature, Long-Term, Implantable Continuous Glucose Monitoring (CGM) system for diabetes patients, this system includes a miniature sensor implanted under the skin and an external wearable unit, e.g. a watch. Its wearable unit reads the signal from the implant and provides basic display and alarms. The company was founded by Yossi Gross in 2007 and is headquartered in Rehovot, Israel. | Electronic Technology |
Medicine On Line Israel (Moli) Ltd.
Medicine On Line Israel (Moli) Ltd. Miscellaneous Commercial ServicesCommercial Services Medicine On Line Israel (Moli) Ltd. is engaged in the field of diabetes . It focuses on: Improving the quality of life and medical treatment for people with diabetes, Performing educational activities, Producing scientific publications, and training people with diabetes. The association was founded by Ludwig Nelken, Herman Wolfson, Dr Liven, and Prof. A. M. Cohen in 1954 and is headquartered in Rishon Le-Zion, Israel. | Commercial Services |
Carmel Biosensors Ltd. | |
Society for The Study of Reproduction | |
Biological Industries Israel Beit-Haemek Ltd.
Biological Industries Israel Beit-Haemek Ltd. Miscellaneous Commercial ServicesCommercial Services Biological Industries Israel Beit-Haemek Ltd. engages in the development and manufacture of cell culture media. Its products include Bio-Pure, BIOTARGET, EZ-PCR, EndoGo, and MSCgo. The company was founded in 1981 and is headquartered in Beit HaEmek, Israel. | Commercial Services |